These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28916492)

  • 1. Overcoming ocular drug delivery barriers through the use of physical forces.
    Huang D; Chen YS; Rupenthal ID
    Adv Drug Deliv Rev; 2018 Feb; 126():96-112. PubMed ID: 28916492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Drug Delivery.
    Yavuz B; Kompella UB
    Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.
    Rodríguez Villanueva J; Navarro MG; Rodríguez Villanueva L
    Int J Pharm; 2016 Sep; 511(1):359-366. PubMed ID: 27436708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
    Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
    Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive strategies for targeting the posterior segment of eye.
    Madni A; Rahem MA; Tahir N; Sarfraz M; Jabar A; Rehman M; Kashif PM; Badshah SF; Khan KU; Santos HA
    Int J Pharm; 2017 Sep; 530(1-2):326-345. PubMed ID: 28755994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye.
    Peynshaert K; Devoldere J; De Smedt SC; Remaut K
    Adv Drug Deliv Rev; 2018 Feb; 126():44-57. PubMed ID: 28939376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell penetrating peptides in ocular drug delivery: State of the art.
    Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
    J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric microneedles for the eye: An overview of advances and ocular applications for minimally invasive drug delivery.
    Mulkutkar M; Damani M; Sawarkar S
    Eur J Pharm Biopharm; 2024 Apr; 197():114209. PubMed ID: 38336234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of microneedles in delivering drugs for various ocular diseases.
    Gupta P; Yadav KS
    Life Sci; 2019 Nov; 237():116907. PubMed ID: 31606378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the applications of dissolving polymer microneedles for delivering drugs in ocular diseases].
    Wang SM; Lin S; Nan KH
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):960-966. PubMed ID: 37936365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
    Gote V; Ansong M; Pal D
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the Application of Microneedles in Eye Disorders and the Proposal of the Upgraded Microneedle with Spinule.
    Yang Q; Zhang T; Wu Y; Liang Q; Zhao W; Liu R; Jin X
    Pharm Res; 2024 Feb; 41(2):203-222. PubMed ID: 38337104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.